TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants

Clinical trial NCT05236777 · COMPLETED

Trial details

NCT number: NCT05236777
Sponsor: Biogen
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2019-01-01
Primary completion: 2025-04-30
Enrollment: 675

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.